Literature DB >> 24727868

Does it Matter if we get it right? Impact of appropriateness of empiric antimicrobial therapy among surgical patients.

Stephen W Davies1, Jimmy T Efird, Christopher A Guidry, Tjasa Hranjec, Rosemarie Metzger, Brian R Swenson, Robert G Sawyer.   

Abstract

Previous studies have shown conflicting evidence regarding the impact of inappropriate, initial antibiotic therapy. The purpose of this study was to evaluate the impact of inappropriate empiric antimicrobial therapy for the treatment of infection among surgical patients. We hypothesized that inappropriate empiric antimicrobial therapy would predict increased mortality risk compared with appropriate therapy. This was a retrospective analysis of a prospectively maintained database of all surgical patients admitted to a tertiary care center from 1996 to 2007 and treated for sepsis. "Appropriate" empiric antibiotic treatment was determined by sensitivity testing. Demographics and comorbidities, infection sites, infection organisms, and outcomes were compared between inappropriately and appropriately treated groups. Multivariable log-binomial regression was performed. There were 2,855 patients (7,158 infectious episodes) identified by culture analysis as either appropriately or inappropriately treated. Three hundred seventeen (15%) inappropriately treated infectious episodes resulted in death compared with 718 (14%) of the appropriately treated infectious episodes. After adjusting for statistically significant variables, inappropriately treated episodes of infection were not found to be associated with an increased risk for mortality compared with appropriately treated episodes of infection (relative risk, 1.0; 95% confidence interval, 0.99 - 1.02; P = 0.36). Our study observed no difference in mortality between appropriately and inappropriately treated infections within a surgical population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24727868      PMCID: PMC4134367          DOI: 10.1097/SHK.0000000000000192

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  33 in total

1.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 2.  Impact of antimicrobial resistance on the treatment and outcome of patients with sepsis.

Authors:  Silvia Figueiredo Costa
Journal:  Shock       Date:  2008-10       Impact factor: 3.454

3.  Benchmarking the incidence and mortality of severe sepsis in the United States.

Authors:  David F Gaieski; J Matthew Edwards; Michael J Kallan; Brendan G Carr
Journal:  Crit Care Med       Date:  2013-05       Impact factor: 7.598

4.  A comparison of predictive outcomes of APACHE II and SAPS II in a surgical intensive care unit.

Authors:  J McNelis; C Marini; R Kalimi; A Jurkiewicz; G Ritter; I Nathan
Journal:  Am J Med Qual       Date:  2001 Sep-Oct       Impact factor: 1.852

5.  Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.

Authors:  Alexis Tabah; Despoina Koulenti; Kevin Laupland; Benoit Misset; Jordi Valles; Frederico Bruzzi de Carvalho; José Artur Paiva; Nahit Cakar; Xiaochun Ma; Philippe Eggimann; Massimo Antonelli; Marc J M Bonten; Akos Csomos; Wolfgang A Krueger; Adam Mikstacki; Jeffrey Lipman; Pieter Depuydt; Aurélien Vesin; Maité Garrouste-Orgeas; Jean-Ralph Zahar; Stijn Blot; Jean Carlet; Christian Brun-Buisson; Claude Martin; Jordi Rello; Georges Dimopoulos; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2012-09-26       Impact factor: 17.440

6.  Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.

Authors:  R Phillip Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven A Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Crit Care Med       Date:  2013-02       Impact factor: 7.598

7.  Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).

Authors:  Olivier Leroy; Jean-Pierre Gangneux; Philippe Montravers; Jean-Paul Mira; François Gouin; Jean-Pierre Sollet; Jean Carlet; Jacques Reynes; Michel Rosenheim; Bernard Regnier; Olivier Lortholary
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

Review 8.  Role of biomarkers in sepsis care.

Authors:  Ravi S Samraj; Basilia Zingarelli; Hector R Wong
Journal:  Shock       Date:  2013-11       Impact factor: 3.454

9.  Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study.

Authors:  Tjasa Hranjec; Laura H Rosenberger; Brian Swenson; Rosemarie Metzger; Tanya R Flohr; Amani D Politano; Lin M Riccio; Kimberley A Popovsky; Robert G Sawyer
Journal:  Lancet Infect Dis       Date:  2012-08-28       Impact factor: 25.071

10.  Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project).

Authors:  M T Montagna; G Caggiano; G Lovero; O De Giglio; C Coretti; T Cuna; R Iatta; M Giglio; L Dalfino; F Bruno; F Puntillo
Journal:  Infection       Date:  2013-03-06       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.